Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?

Guilleminault L, Saint-Hilaire A, Favelle O, Caille A, Boissinot E, Henriet AC, Diot P, Marchand-Adam S.

Respir Med. 2013 Nov;107(11):1789-96. doi: 10.1016/j.rmed.2013.07.007. Epub 2013 Sep 5.

2.

Influence of jet nebulization and oxygen delivery on the fraction of inspired oxygen: an experimental model.

Caille V, Ehrmann S, Boissinot E, Perrotin D, Diot P, Dequin PF.

J Aerosol Med Pulm Drug Deliv. 2009 Sep;22(3):255-61. doi: 10.1089/jamp.2008.0718.

PMID:
19466907
3.

Comparative analysis of different scintigraphic approaches to assess pulmonary ventilation.

Magnant J, Vecellio L, de Monte M, Grimbert D, Valat C, Boissinot E, Guilloteau D, Lemarié E, Diot P.

J Aerosol Med. 2006 Summer;19(2):148-59.

PMID:
16796539
4.

Relationship between occupational risk factors and severity markers of systemic sclerosis.

Magnant J, de Monte M, Guilmot JL, Lasfargues G, Diot P, Asquier E, Degenne D, Boissinot E, Diot E.

J Rheumatol. 2005 Sep;32(9):1713-8.

PMID:
16142866
5.

[Dyspnea and morphine aerosols in the palliative care of lung cancer].

Grimbert D, Lubin O, de Monte M, Vecellio None L, Perrier M, Carré P, Lemarié E, Boissinot E, Diot P.

Rev Mal Respir. 2004 Dec;21(6 Pt 1):1091-7. French.

PMID:
15767953
6.

Residual gravimetric method to measure nebulizer output.

Vecellio None L, Grimbert D, Bordenave J, Benoit G, Furet Y, Fauroux B, Boissinot E, De Monte M, Lemarié E, Diot P.

J Aerosol Med. 2004 Spring;17(1):63-71.

PMID:
15120014
7.

Characteristics of EPI-hNE4 aerosol: a new elastase inhibitor for treatment of cystic fibrosis.

Grimbert D, Vecellio L, Delépine P, Attucci S, Boissinot E, Poncin A, Gauthier F, Valat C, Saudubray F, Antonioz P, Diot P.

J Aerosol Med. 2003 Summer;16(2):121-9.

PMID:
12823906
8.

Urinary excretion reflects lung deposition of aminoglycoside aerosols in cystic fibrosis.

Dequin PF, Faurisson F, Lemarié E, Delatour F, Marchand S, Valat C, Boissinot E, de Gialluly C, Diot P.

Eur Respir J. 2001 Aug;18(2):316-22.

9.

Aerosols and anti-infectious agents.

Diot P, Dequin PF, Rivoire B, Gagnadoux F, Faurisson F, Diot E, Boissinot E, Le Pape A, Palmer L, Lemarié E.

J Aerosol Med. 2001 Spring;14(1):55-64. Review.

PMID:
11495486
10.

Validation of laser diffraction method as a substitute for cascade impaction in the European Project for a Nebulizer Standard.

Vecellio None L, Grimbert D, Becquemin MH, Boissinot E, Le Pape A, Lemarié E, Diot P.

J Aerosol Med. 2001 Spring;14(1):107-14.

PMID:
11495481
11.

[Strategy for early diagnosis of lung involvement in systemic scleroderma].

Diot E, Valat C, Boissinot E, Giraudeau B, Asquier E, Guilmot JL, Lemarié E, Diot P.

Rev Mal Respir. 2000 Dec;17(6):1073-80. Review. French.

PMID:
11217502
12.

[Serum procalcitonin and respiratory tract infections].

Zarka V, Valat C, Lemarié E, Boissinot E, Carré P, Besnard JC, Diot P.

Rev Pneumol Clin. 1999 Dec;55(6):365-9. French.

PMID:
10685471
13.

[Anti-infective aerosols].

Diot P, Dequin PF, Rivoire B, Gagnadoux F, Faurisson F, Diot E, Boissinot E, Lemarié E.

Rev Mal Respir. 1999 Jun;16(3):277-85. Review. French.

PMID:
10472633
14.

Relationship between abnormalities on high-resolution CT and pulmonary function in systemic sclerosis.

Diot E, Boissinot E, Asquier E, Guilmot JL, Lemarié E, Valat C, Diot P.

Chest. 1998 Dec;114(6):1623-9.

PMID:
9872198
15.

Nebulization and anti-Pseudomonas aeruginosa activity of colistin.

Diot P, Gagnadoux F, Martin C, Ellataoui H, Furet Y, Breteau M, Boissinot E, Lemarié E.

Eur Respir J. 1997 Sep;10(9):1995-8.

16.

[Hematopoietic growth factors and anti-infective respiratory defenses].

Gagnadoux F, Diot P, Boissinot E, Lemarié E.

Rev Mal Respir. 1997 Apr;14(2):93-9. Review. French.

PMID:
9198845
17.

Community acquired pneumonia in adults: a study comparing clinical features and outcome in Africa (Republic of Guinea) and Europe (France).

Sow O, Frechet M, Diallo AA, Soumah S, Conde MK, Diot P, Boissinot E, Lemarié E.

Thorax. 1996 Apr;51(4):385-8.

18.

Predictive value of serum III procollagen for diagnosis of pulmonary involvement in patients with scleroderma.

Diot E, Diot P, Valat C, Boissinot E, Asquier E, Lemarie E, Guilmot JL.

Eur Respir J. 1995 Sep;8(9):1559-65.

19.

Acute respiratory infections in children: a community-based study comparing a primary health center and a pediatric unit, Republic of Guinea.

Sow O, Diallo AB, Haba F, Diot P, Boissinot E, Lemarie E.

Tuber Lung Dis. 1995 Feb;76(1):4-10.

PMID:
7718846
20.

[Chronic course of reactive bronchial dysfunction syndrome. Apropos of 6 further cases].

Rivoire B, Carré P, Boissinot E, Renjard L, Lasfargues G, Lavandier M.

Rev Mal Respir. 1995;12(5):471-7. French.

PMID:
8560079
21.
22.

Direct isotopic assessment of aerosolized pentamidine deposition: influence of nebuliser.

Diot P, Le Pape A, Becquemin MH, Besnier JM, Boissinot E, Bastides F, Benjemaa M, Choutet P, Lemarie E.

Eur J Med. 1993 Oct-Nov;2(8):484-8.

PMID:
8258049
23.

[Evaluation of the mean annual risk of tuberculosis infection in the town of Conakry].

Sow O, Diallo MP, Camara B, Diallo MB, Diallo A, Boissinot E, Lemarié E.

Rev Mal Respir. 1990;7(4):355-60. French.

PMID:
2399355
24.

[Bronchial provocation tests in 59 asthmatic children. Comparison with skin tests and specific serum allergens].

Souille B, Boissinot E, Terrisse M, Duguet-Gruau F, Varaigne F, Moline J.

Rev Mal Respir. 1987;4(5):225-30. French.

PMID:
3432710
25.

Bacterial atmospheric contamination in wastewater treatment plants.

Boutin P, Torre M, Moline J, Boissinot E.

Experientia Suppl. 1987;51:365-70. No abstract available.

PMID:
2958345
26.

[Hypercapnic status asthmaticus. Rapid reversibility of hypercapnia under medical treatment].

Perrotin D, Boissinot E, Ginies G.

Presse Med. 1986 Oct 18;15(36):1809-12. French.

PMID:
2947157
27.

[Measurement of peak expiratory flow and altitude].

Massen H, Boissinot E, Moline J.

Cah Anesthesiol. 1986 Jun-Jul;34(4):341-3. French.

PMID:
3756572
28.

[Measurement of the peak expiratory flow rate and altitude].

Massen H, Boissinot E, Moline J.

Agressologie. 1986 May;27(6):497-8. French. No abstract available.

PMID:
3777343
29.

Alveolar macrophage dysfunction in malignant lung tumours.

Lemarie E, Carre P, Legrand MF, Lavandier M, Boissinot E, Renoux M, Renoux G.

Thorax. 1984 Jun;39(6):448-52.

30.

[Atmospheric and respiratory contamination by waste water aerosols].

Boutin P, Moline J, Torre M, Boissinot E.

Rev Mal Respir. 1984;1(2):125-31. French.

PMID:
6463354
31.

[Prevention of pneumoconiosis in the hard metal industry].

Moline J, Boissinot E, Rougereau A, Guiller A, Rosmorduc B.

Nouv Presse Med. 1980 Oct 11;9(37):2735. French. No abstract available.

PMID:
7433072
32.

[Functional respiratory exploration of post-traumatic fat embolisms treated by controlled ventilation].

Choutet P, Ginies G, Sonneville A, Lamisse F, Moline J, Boissinot E, Loubrieux JF.

Bronchopneumologie. 1978 May-Jun;28(3):241-51. French. No abstract available.

PMID:
756791
33.

The radiospirometric flow-volume diagram recording technique and comparative study with conventional spirometry.

Marchal C, Itti R, Philippe L, Boissinot E, Moline J, Lavandier M.

Eur J Nucl Med. 1977 Sep 30;2(3):165-71.

PMID:
913430
34.

[Transfer of carbon monoxide at stable pressure and under spirometry in children. Norms].

Moline J, Boissinot E, Roullier A, Homasson JP, Benardeau MH, Marchal C.

Lille Med. 1976 Oct;21(8):652-61. French. No abstract available.

PMID:
1004115
35.

[Survival of patients treated with bleomycin and evolution of decreased transfer of carbon monoxide].

Moline J, Homasson JP, Garand G, Gasse J, Boissinot E, Roullier A.

Therapie. 1976 Mar-Apr;31(2):241-6. French. No abstract available.

PMID:
59956
36.

[Letter: Obstruction of the upper airways. Value of the flow-volume loop].

Homasson JP, Boissinot E, Lavandier M, Moline J?.

Nouv Presse Med. 1975 Apr 26;4(17):1288-9. French. No abstract available.

PMID:
1153287
37.

[Letter: Consistency of alteration of alveolo-capillary transfer in man, due to an anti-tumor agent (bleomycin)].

Homasson JP, Boissinot E, Roullier A, Moline J.

Nouv Presse Med. 1974 Apr 27;3(17):1103. French. No abstract available.

PMID:
4135576

Supplemental Content

Loading ...
Support Center